Home | Site Map | About | Contact 
  The scientific approach to weight loss and maintenance. Indepenent, hype-free research.
 
Weight Loss Guide
 Weight Loss Basics
 Diets & Dieting
 Drug Therapy
 Supplements
 Weight Loss Surgery
 Tools & Calculators
 
News & Research
 Weight Loss News
 Published Studies
   > Drugs
   > Diets
   > Supplements
   > Surgery
   > Lifestyle
 Clinical Trials
 
 
 
 
 
 
 
   
You are here: Weight Loss News >

Wieght loss & maintenance news: orlistat (Xenical)

We have compiled the list of news articles related to orlistat (Xenical) from online health/medical sources selected based on their reputation and reliability.

Scheduling Of Orlistat - National Drugs And Poisons Schedule Committee, Australia
Obesity / Weight Loss / Fitness News From Medical News Today -- 2007-02-27
The National Drugs and Poisons Schedule Committee (NDPSC) reconsidered the scheduling and advertising status of orlistat (contained in the medicine Xenical) at its February 2007 meeting. After reviewing a large number of submissions from consumer, industry and professional bodies, the NDPSC has decided that orlistat should be retained in Schedule 3 as a Pharmacist Only medicine. [click link for full article]...more >>

GlaxoSmithKline Acquires Exclusive Rights To Over-the-counter Orlistat For Markets Outside The US From Roche Group
Obesity / Weight Loss / Fitness News From Medical News Today -- 2007-02-25
GlaxoSmithKline plc (GSK) announced today that it has acquired from Roche Group exclusive rights to the weight-loss medicine, orlistat, for over-the-counter (OTC) use in markets outside the US, excluding Japan. GSK anticipates filing orlistat for OTC approval in Europe and certain key international markets by the end of 2007. [click link for full article]...more >>

Scheduling Of Orlistat - National Drugs And Poisons Schedule Committee, Australia
Obesity / Weight Loss / Fitness News From Medical News Today -- 2007-02-27
The National Drugs and Poisons Schedule Committee (NDPSC) reconsidered the scheduling and advertising status of orlistat (contained in the medicine Xenical) at its February 2007 meeting. After reviewing a large number of submissions from consumer, industry and professional bodies, the NDPSC has decided that orlistat should be retained in Schedule 3 as a Pharmacist Only medicine. [click link for full article]...more >>


Back to Weight Loss News

     
-- advertisements --


Copyright © 2006 by Weight-Loss-Science.com
All inormation is for education purposes only and should not be considered as a medical advice.